These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2317492)

  • 21. Potentiation of the humoral response of intravenous antigen by splenotropic liposomes.
    Liu DX; Wada A; Huang L
    Immunol Lett; 1992 Feb; 31(2):177-81. PubMed ID: 1740352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted delivery of doxorubicin via estrone-appended liposomes.
    Rai S; Paliwal R; Vaidya B; Khatri K; Goyal AK; Gupta PN; Vyas SP
    J Drug Target; 2008 Jul; 16(6):455-63. PubMed ID: 18604658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Method for rapid separation of liposome-associated doxorubicin from free doxorubicin in plasma.
    Thies RL; Cowens DW; Cullis PR; Bally MB; Mayer LD
    Anal Biochem; 1990 Jul; 188(1):65-71. PubMed ID: 2221370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge.
    Dadashzadeh S; Mirahmadi N; Babaei MH; Vali AM
    J Control Release; 2010 Dec; 148(2):177-86. PubMed ID: 20800629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microfluidic-assisted fabrication of phosphatidylcholine-based liposomes for controlled drug delivery of chemotherapeutics.
    Gkionis L; Aojula H; Harris LK; Tirella A
    Int J Pharm; 2021 Jul; 604():120711. PubMed ID: 34015381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposomes for the sustained drug release in vivo.
    Blume G; Cevc G
    Biochim Biophys Acta; 1990 Nov; 1029(1):91-7. PubMed ID: 2223816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kanamycin incorporation in lipid vesicles prepared by ethanol injection designed for tuberculosis treatment.
    Justo OR; Moraes AM
    J Pharm Pharmacol; 2005 Jan; 57(1):23-30. PubMed ID: 15638989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics.
    Mourtas S; Fotopoulou S; Duraj S; Sfika V; Tsakiroglou C; Antimisiaris SG
    Colloids Surf B Biointerfaces; 2007 Apr; 55(2):212-21. PubMed ID: 17223020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties.
    Krishna R; Webb MS; St Onge G; Mayer LD
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1206-12. PubMed ID: 11504822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended in vivo blood circulation time of fluorinated liposomes.
    Santaella C; Frézard F; Vierling P; Riess JG
    FEBS Lett; 1993 Dec; 336(3):481-4. PubMed ID: 8282115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative immunotoxicity of free doxorubicin and doxorubicin encapsulated in cardiolipin liposomes.
    Rahman A; Ganjei A; Neefe JR
    Cancer Chemother Pharmacol; 1986; 16(1):28-34. PubMed ID: 3484382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphatic absorption and tissue disposition of liposome-entrapped [14C]adriamycin following intraperitoneal administration to rats.
    Parker RJ; Hartman KD; Sieber SM
    Cancer Res; 1981 Apr; 41(4):1311-7. PubMed ID: 7214320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Self-Assembly of Bile Acid-Phospholipids Controls the Delivery of Doxorubicin and Mice Survivability.
    Sreekanth V; Medatwal N; Pal S; Kumar S; Sengupta S; Bajaj A
    Mol Pharm; 2017 Aug; 14(8):2649-2659. PubMed ID: 28665132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
    Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
    J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.
    Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S
    J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats.
    Kim CK; Han JH
    J Microencapsul; 1995; 12(4):437-46. PubMed ID: 8583318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged circulation time of doxorubicin-loaded liposomes coated with a modified polyvinyl alcohol after intravenous injection in rats.
    Takeuchi H; Kojima H; Toyoda T; Yamamoto H; Hino T; Kawashima Y
    Eur J Pharm Biopharm; 1999 Sep; 48(2):123-9. PubMed ID: 10469930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loading of doxorubicin into liposomes by forming Mn2+-drug complexes.
    Cheung BC; Sun TH; Leenhouts JM; Cullis PR
    Biochim Biophys Acta; 1998 Nov; 1414(1-2):205-16. PubMed ID: 9804955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dexamethasone incorporating liposomes: effect of lipid composition on drug trapping efficiency and vesicle stability.
    Tsotas VA; Mourtas S; Antimisiaris SG
    Drug Deliv; 2007 Oct; 14(7):441-5. PubMed ID: 17994361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.